FDA Inspection 1092128 — Median Technologies
The FDA completed an inspection of Median Technologies on May 3, 2019 in Valbonne. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 3, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Valbonne (France)
Additional Details
Sponsor, Contract Research Organization